Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
Antwerp, Belgium, September 11, 2026 — Agomab Therapeutics NV NASDAQ:AGMB ("Agomab" or the "Company"), a clinical-stage biopharmaceutical company focused on fibro-inflammatory diseases, today announced that shareholders approved all resolutions submitted for consideration at the Company's Special a…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.